The Core Issue: Failure to Warn Patients of Severe Risks The central argument in the GLP-1 lawsuits is that manufacturers like Novo Nordisk and Eli Lilly knew, or should have known, about the risk of severe side effects like stomach paralysis and bowel obstruction but failed to adequately warn doctors and patients
Diabetes Metab 43(5):430437 Nslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ et al (1999) Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men
If you have tried multiple compounding pharmacies, verified storage and dosing, and still see no results, switching to brand-name eliminates all compounding variables
Exercise: Incorporate regular physical activity into your routine, aiming for at least 30 minutes of moderate-intensity exercise most days of the week
2025;9(5):e2401171
The most common side effects are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, occurring in approximately 2040% of patients